Alterations in regional myocardial distribution and arrhythmogenic effects of aprindine produced by coronary artery occlusion in the dog

Stanley Nattel, Donal H. Pedersen, Douglas P. Zipes

Research output: Contribution to journalArticle

68 Citations (Scopus)

Abstract

Summary: Little information exists regarding the effects of coronary artery occlusion on the distribution and actions of antiarrhythmic agents. We administered aprindine to dogs before, 5 min after, and 24 h after one-stage left anterior descending coronary artery (LAD) occlusion. Coronary artery occlusion performed after aprindine administration slowed the rate of disappearance of aprindine from the ischaemic zone compared with the normal zone, so that ischaemic zone aprindine concentrations averaged more than twice normal zone aprindine concentrations 1 h after LAD occlusion. When LAD occlusion was performed before aprindine administration, ischaemic zone aprindine concentrations were initially less than 15% of normal zone aprindine concentrations and increased with time to approach half of normal zone aprindine concentrations 70 min after LAD occlusion.Seventeen of 35 dogs (49%) receiving aprindine before LAD occlusion experienced sustained ventricular tachycardia or ventricular fibrillation, compared with 5/34 (14%) receiving aprindine immediately after LAD occlusion (P < 0.01), 1/10 (10%) undergoing LAD occlusion without receiving aprindine (P < 0.05) and 0/16 receiving aprindine without LAD occlusion (P < 0.01). Aprindine administered 24 h after CO reduced premature ventricular complexes from a mean of 35 to 12 per 100 beats (P < 0.01). These studies indicate the temporal relationship between aprindine administration and LAD occlusion importantly modifies the regional myocardial distribution of aprindine and its effects on ventricular arrhythmias after coronary artery occlusion.

Original languageEnglish
Pages (from-to)80-85
Number of pages6
JournalCardiovascular Research
Volume15
Issue number2
DOIs
StatePublished - Feb 1981

Fingerprint

Aprindine
Coronary Artery
Coronary Occlusion
Occlusion
Coronary Vessels
Dogs
Dog
Antiarrhythmic Agents
Ventricular Arrhythmias
Ventricular Tachycardia
Ventricular Fibrillation
Beat

ASJC Scopus subject areas

  • Statistics, Probability and Uncertainty
  • Applied Mathematics
  • Physiology (medical)
  • Physiology
  • Cardiology and Cardiovascular Medicine

Cite this

Alterations in regional myocardial distribution and arrhythmogenic effects of aprindine produced by coronary artery occlusion in the dog. / Nattel, Stanley; Pedersen, Donal H.; Zipes, Douglas P.

In: Cardiovascular Research, Vol. 15, No. 2, 02.1981, p. 80-85.

Research output: Contribution to journalArticle

@article{554a77315a694ab9bacece178cab2cde,
title = "Alterations in regional myocardial distribution and arrhythmogenic effects of aprindine produced by coronary artery occlusion in the dog",
abstract = "Summary: Little information exists regarding the effects of coronary artery occlusion on the distribution and actions of antiarrhythmic agents. We administered aprindine to dogs before, 5 min after, and 24 h after one-stage left anterior descending coronary artery (LAD) occlusion. Coronary artery occlusion performed after aprindine administration slowed the rate of disappearance of aprindine from the ischaemic zone compared with the normal zone, so that ischaemic zone aprindine concentrations averaged more than twice normal zone aprindine concentrations 1 h after LAD occlusion. When LAD occlusion was performed before aprindine administration, ischaemic zone aprindine concentrations were initially less than 15{\%} of normal zone aprindine concentrations and increased with time to approach half of normal zone aprindine concentrations 70 min after LAD occlusion.Seventeen of 35 dogs (49{\%}) receiving aprindine before LAD occlusion experienced sustained ventricular tachycardia or ventricular fibrillation, compared with 5/34 (14{\%}) receiving aprindine immediately after LAD occlusion (P < 0.01), 1/10 (10{\%}) undergoing LAD occlusion without receiving aprindine (P < 0.05) and 0/16 receiving aprindine without LAD occlusion (P < 0.01). Aprindine administered 24 h after CO reduced premature ventricular complexes from a mean of 35 to 12 per 100 beats (P < 0.01). These studies indicate the temporal relationship between aprindine administration and LAD occlusion importantly modifies the regional myocardial distribution of aprindine and its effects on ventricular arrhythmias after coronary artery occlusion.",
author = "Stanley Nattel and Pedersen, {Donal H.} and Zipes, {Douglas P.}",
year = "1981",
month = "2",
doi = "10.1093/cvrese/15.2.80",
language = "English",
volume = "15",
pages = "80--85",
journal = "Cardiovascular Research",
issn = "0008-6363",
publisher = "Oxford University Press",
number = "2",

}

TY - JOUR

T1 - Alterations in regional myocardial distribution and arrhythmogenic effects of aprindine produced by coronary artery occlusion in the dog

AU - Nattel, Stanley

AU - Pedersen, Donal H.

AU - Zipes, Douglas P.

PY - 1981/2

Y1 - 1981/2

N2 - Summary: Little information exists regarding the effects of coronary artery occlusion on the distribution and actions of antiarrhythmic agents. We administered aprindine to dogs before, 5 min after, and 24 h after one-stage left anterior descending coronary artery (LAD) occlusion. Coronary artery occlusion performed after aprindine administration slowed the rate of disappearance of aprindine from the ischaemic zone compared with the normal zone, so that ischaemic zone aprindine concentrations averaged more than twice normal zone aprindine concentrations 1 h after LAD occlusion. When LAD occlusion was performed before aprindine administration, ischaemic zone aprindine concentrations were initially less than 15% of normal zone aprindine concentrations and increased with time to approach half of normal zone aprindine concentrations 70 min after LAD occlusion.Seventeen of 35 dogs (49%) receiving aprindine before LAD occlusion experienced sustained ventricular tachycardia or ventricular fibrillation, compared with 5/34 (14%) receiving aprindine immediately after LAD occlusion (P < 0.01), 1/10 (10%) undergoing LAD occlusion without receiving aprindine (P < 0.05) and 0/16 receiving aprindine without LAD occlusion (P < 0.01). Aprindine administered 24 h after CO reduced premature ventricular complexes from a mean of 35 to 12 per 100 beats (P < 0.01). These studies indicate the temporal relationship between aprindine administration and LAD occlusion importantly modifies the regional myocardial distribution of aprindine and its effects on ventricular arrhythmias after coronary artery occlusion.

AB - Summary: Little information exists regarding the effects of coronary artery occlusion on the distribution and actions of antiarrhythmic agents. We administered aprindine to dogs before, 5 min after, and 24 h after one-stage left anterior descending coronary artery (LAD) occlusion. Coronary artery occlusion performed after aprindine administration slowed the rate of disappearance of aprindine from the ischaemic zone compared with the normal zone, so that ischaemic zone aprindine concentrations averaged more than twice normal zone aprindine concentrations 1 h after LAD occlusion. When LAD occlusion was performed before aprindine administration, ischaemic zone aprindine concentrations were initially less than 15% of normal zone aprindine concentrations and increased with time to approach half of normal zone aprindine concentrations 70 min after LAD occlusion.Seventeen of 35 dogs (49%) receiving aprindine before LAD occlusion experienced sustained ventricular tachycardia or ventricular fibrillation, compared with 5/34 (14%) receiving aprindine immediately after LAD occlusion (P < 0.01), 1/10 (10%) undergoing LAD occlusion without receiving aprindine (P < 0.05) and 0/16 receiving aprindine without LAD occlusion (P < 0.01). Aprindine administered 24 h after CO reduced premature ventricular complexes from a mean of 35 to 12 per 100 beats (P < 0.01). These studies indicate the temporal relationship between aprindine administration and LAD occlusion importantly modifies the regional myocardial distribution of aprindine and its effects on ventricular arrhythmias after coronary artery occlusion.

UR - http://www.scopus.com/inward/record.url?scp=0019448975&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0019448975&partnerID=8YFLogxK

U2 - 10.1093/cvrese/15.2.80

DO - 10.1093/cvrese/15.2.80

M3 - Article

VL - 15

SP - 80

EP - 85

JO - Cardiovascular Research

JF - Cardiovascular Research

SN - 0008-6363

IS - 2

ER -